VOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST) Meeting Abstract
| Authors: | Bauer, S.; George, S.; Kang, Y. K.; Tap, W. D.; Zhou, T.; Picazio, N.; Boral, A. L.; Heinrich, M. |
| Abstract Title: | VOYAGER: An open-label, randomised, phase III study of avapritinib vs regorafenib in patients (pts) with locally advanced (adv) metastatic or unresectable gastrointestinal stromal tumour (GIST) |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy299.058 |
| End Page: | 595 |
| Language: | English |
| ACCESSION: | WOS:000459277304031 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy299.058 |
| Notes: | Meeting Abstract: 1662TiP -- Appears on page viii595 of the abstract book -- Source: Wos |
